Search
Now showing items 1-5 of 5
(Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2012)
Background
Acute rejection (AR) episodes in renal transplant recipients are suspected when plasma creatinine is elevated and other potential causes out ruled. Graft biopsies are however needed for definite ...
(Journal article / Tidsskriftartikkel / Published version; Peer reviewed, 2014)
Aims The aim was to develop a theory-based population pharmacokinetic model of tacrolimus in adult kidney transplant recipients and to externally evaluate this model and two previous empirical models.
Methods Data were ...
(Journal article / Tidsskriftartikkel / Published version; Peer reviewed, 2014)
Purpose To identify patient characteristics that influence tacrolimus individual dose requirement in kidney transplant recipients.
Methods Data on forty-four 12-h pharmacokinetic profiles from 29 patients and trough ...
(Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2017)
Background: Mycophenolic acid (MPA) is the active immunosuppressive substance in both mycophenolate mofetil and mycophenolate sodium, and it is widely used after organ transplantation. In women, taking MPA is teratogenic ...
(Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2019)
OBJECTIVE Sodium–glucose cotransporter 2 (SGLT2) inhibitors have lately become the recommended treatment in patients with type 2 diabetes and high cardiovascular risk. Patients with posttransplant diabetes mellitus (PTDM) ...
RSS 2.0